Is a complete VOR research report available?

No complete published report is available for Vor Biopharma Inc. (VOR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Vor Biopharma Inc. (VOR)

NASDAQ: VOR · USD

$19.3

+0.28 (+1.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first VOR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1B
Net income (ttm)	-883.1M
EPS (ttm)	-$46.3
Shares out	54.2M
Volume	638,804
Beta	1.70
Price target	$37.9	+96.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -883.1M
EPS (ttm): -$46.3
Market cap: 1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All VOR indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001817229
Company name	Vor Biopharma Inc.
Country	United States
Country code	US
Cusip	929033207
Employees	76
Employees Change	-83%
Employees Change Percent	-52.2
Enterprise value	$555M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-05
Isin	US9290332074
Last refreshed	2026-07-27
Market cap	$1B
Market cap category	Small-Cap
Price	$19.26
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.69
Sic	2836
Symbol	VOR
Website	https://www.vorbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-84.62%
FCF yield	-14.44%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-883.1M
Net Income Growth Years	0%
Profit Per Employee	$-11.6M
ROA	-69.76
Roa5y	-39.03
ROCE	-76.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-53.95%
Cagr3y	-34%
Cagr5y	-40.58%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$506.7M
Cash	$491.5M
Current Assets	$500.8M
Current Liabilities	$16.1M
Debt	$2.9M
Equity	$-150.4M
Liabilities	$657.2M
Long Term Assets	$6M
Long Term Liabilities	$641.1M
Net Cash	$488.6M
Net Cash By Market Cap	$46.82
Net Cash Growth	1,570.21%
Tangible Book Value	$-150.4M
Tangible Book Value Per Share	$-2.78
WACC	13.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	31.15
Net Working Capital	$-6.5M
Quick ratio	30.57
Working Capital	$484.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-359.89%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-53.92%
200-day SMA	15.82
3Y total return	-71.25%
50-day SMA	16.19
50-day SMA vs 200-day SMA	50over200
5Y total return	-92.59%
All Time High	1,272.4
All Time High Change	-98.49%
All Time High Date	2021-02-05
All Time Low	2.62
All Time Low Change	634.55%
All Time Low Date	2025-05-09
ATR	1.45
Beta	1.7
Beta1y	2.19
Beta2y	4.73
Ch YTD	47.25
High	19.63
High52	53
High52 Date	2025-07-29
High52ch	-63.66%
Low	18.36
Low52	6.5
Low52 Date	2025-11-20
Low52ch	196.31%
Ma50ch	19%
Premarket Change Percent	0.63
Premarket Price	$19.1
Price vs 200-day SMA	21.71%
RSI	57.57
RSI Monthly	38.08
RSI Weekly	56.42
Sharpe ratio	-0.09x
Sortino ratio	-0.08
Total Return	-359.89%
Tr YTD	47.25
Tr1m	29.7%
Tr1w	6.47%
Tr3m	31.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	5
Analyst Price Target Top	$34.75
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.7
Operating Income	$-343.8M
Price target	$37.88
Price Target Change	$96.68
Price Target Change Top	$80.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,667,143%
Float Percent	65.82%
Shares Insiders	2.19%
Shares Institutions	46.87%
Shares Out	54,185,877
Shares Qo Q	111.92%
Shares Yo Y	359.89%
Short Float	20.44%
Short Ratio	3.86
Short Shares	13.45

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-176.5M
Average Volume	1,756,049.35x
Bv Per Share	-2.78
CAPEX	$-758,000
Ch1m	29.7
Ch1w	6.47
Ch1y	-53.92
Ch3m	31.74
Ch3y	-71.25
Ch5y	-92.59
Ch6m	16.09
Change	1.48%
Change From Open	1.42
Close	18.98
Days Gap	0.05
Depreciation Amortization	2,090,000
Dollar Volume	12,303,365
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-373.5M
EBITDA	$-367.5M
EPS	$-46.32
F Score	2
FCF	$-150.7M
FCF EV Yield	-27.14x
FCF Per Share	$-2.78
Financing CF	579,283,000
Fiscal Year End	December
Founded	2,015
Investing CF	-311,809,000
Ipr	7
Iprfo	-97.71
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2025-09-19
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	15.05
Ma150ch	27.98%
Ma20	18.84
Ma20ch	2.23%
Net CF	117,581,000
Next Earnings Date	2026-08-11
Open	18.99
Optionable	Yes
Position In Range	70.87
Post Close	19.26
Postmarket Change Percent	1.77
Postmarket Price	$19.6
Ppne	3,392,000
Pre Close	18.98
Price Date	2026-07-24
Relative Volume	0.36x
Share Based Comp	25,849,000
Tr6m	16.09%
Us State	Massachusetts
Volume	638,804

Vor Biopharma Inc. (VOR)

Coverage state: Market snapshot only — no published research

Generate the first VOR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · VOR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VOR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on VOR

Frequently asked questions